Fundraising Fox
🦊/People
Sign in

Miguel Forte

Investor

Advisor at Delin Ventures · CEO at Kiji-tx website

Brussels Metropolitan Area

Find your path to Miguel

329 people in our graph share verified history with Miguel — schools, employers, funds. One of them is your warm intro.

Ben PerryunlockedMiguel: together at UCB (2006–2008)
Miguel: together at GSK
Miguel: together at AdBio partners
Miguel: together at ISCT, International Society for Cell & Gene Therapy

About

Miguel Forte is Chief Executive Officer of Kiji Therapeutics and serves as an ARM Board Member. He holds an MD and PhD and brings over 30 years of experience across clinical, academic, regulatory, and pharmaceutical industry settings, with expertise in research and development, manufacturing, regulatory affairs, medical affairs, and general management. He previously served as President of the International Society for Cell & Gene Therapy.

CEO at Kiji-tx website

Intro paths

→

In turn, Miguel can intro founders to Kiji-tx website's investors below.

Kiji-tx website's investors · 1

AdBio partnersParis

Experience

  1. Kiji TherapeuticsChief Executive Officercurrent2023 — presentFrance
  2. ISCT, International Society for Cell & Gene TherapyImmediate Past Presidentcurrent2026 — presentGlobal
  3. ISCT, International Society for Cell & Gene TherapyVice-Chair Industry - Committee on the Ethics of Cell and Gene Therapy (ECGT)current2019 — presentGlobal
  4. ISCT, International Society for Cell & Gene TherapyPresident2024 — 2026
  5. ISCT, International Society for Cell & Gene TherapyBoard Member2018 — 2020Global
  6. ISCT, International Society for Cell & Gene TherapyChief Commercialization Officer2016 — 2020Global
  7. ISCT, International Society for Cell & Gene TherapyChair of Commercialization Committee2014 — 2020Global
  8. ISCT, International Society for Cell & Gene TherapyVice-President Elect European Regional Committee2012 — 2014Europe
  9. Alliance for Regenerative MedicineExecutive Committee Membercurrent2020 — present
  10. Alliance for Regenerative MedicineBoard Membercurrent2019 — presentGlobal
  11. Alliance for Regenerative MedicineMember and Chair of European Advisory Board/Committeecurrent2019 — present
  12. Alliance for Regenerative MedicineChair of Nomination Committee2019 — 2022
  13. Blue Cell TherapeuticsNon Executive Directorcurrent2025 — present
  14. Akatsuki TherapeuticsExecutive Chairmancurrent2025 — present
  15. Swarm OncologyNon Executive Directorcurrent2024 — presentLondon
  16. StemBond TechnologiesNon Executive Directorcurrent2023 — present
  17. StemBond TechnologiesExecutive Chair of Board of Directors2023 — 2025Cambridge, England, United Kingdom
  18. Made ScientificMember of the Board of Advisorscurrent2025 — present
  19. mC4TxFounder and Managing Directorcurrent2017 — presentBrussels Area, Belgium
  20. Faculdade de Farmácia da Universidade de LisboaInvited Associate Professorcurrent2015 — presentLisbon
  21. AdBio partnersEntrepreneur In Residence2022 — 2023Paris, Île-de-France, France
  22. essenscia waterlooBoard Member2021 — 2022Brussels Metropolitan Area
  23. BONE THERAPEUTICS S.A.Chief Executive Officer2020 — 2022Brussels Area, Belgium
  24. Zelluna ImmunotherapyChief Executive Officer2017 — 2019Oslo Area, Norway
  25. BONE THERAPEUTICS S.A.Chief Medical Officer2017Belgium
  26. Universidade de AveiroInvited Associate Professor2010 — 2017Aveiro
  27. TxCellEVP and Chief Operating Officer2015 — 2016Sophia-Antipolis
  28. TxCellSVP Clinical and Regulatory Affairs and Chief Medical Officer2010 — 2015Sophia-Antipolis
  29. UCBVP Global Medical Affairs Inflammation2006 — 2010
  30. Nabi BiopharmaceuticalsVP Clinical, Regulatory and Medical Affairs Europe2004 — 2006
  31. Faculdade de Medicina da Universidade de LisboaAuxiliary Professor of Infections Diseases1992 — 2005Hospital Santa Maria - Lisboa, Portugal
  32. Faculdade de Medicina da Universidade de LisboaConsultant specialist in Infectious Diseases1992 — 1995Hospital Santa Maria - Lisboa, Portugal
  33. Bristol-Myers SquibbVP International Medical Organization, Europe2002 — 2003
  34. Bristol-Myers SquibbExecutive Director, Infectious Diseases, Immunology and Dermatology2000 — 2002
  35. Bristol-Myers SquibbMedical Director, Portugal1998 — 2000
  36. EMEACHMP Member, Portugal1997 — 1998
  37. INFARMEDVice-Chairman New Drugs Committee1996 — 1998
  38. Abbott LaboratoriesMedical Director, Portugal1995 — 1996
  39. GSKMedical Director1995Lisbon, Portugal
  40. University of BirminghamClinical Registrar and Research Fellow1988 — 1992

Skills & more

Infectious Diseases33Biopharmaceuticals25Regulatory Affairs29Clinical Development97Immunology59Translational Medicine5Clinical Trials32VaccinesMedical Affairs46Drug Development59Rheumatology2Dermatology4
+12 morePharmaceuticsBiotechnologyClinical ResearchMarket AccessOncologyHealth EconomicsInflammationMedicinePharmaceutical IndustryCROMedical WritingPharmacology

Languages English · French · Italian · Portuguese · Spanish

From Miguel's professional profile.

Colleagues at Delin Ventures

Alan Barge
Venture Partner at Delin Ventures
Carol Lynch
Advisor at Delin Ventures
Caroline Haegeman
Associate at Delin Ventures
Christopher Spray
Advisor at Delin Ventures
Colin Sims
Partner at Delin Ventures
Igor Linshits
Founder at Delin Ventures
İskender Dirik
Partner at Delin Ventures
Jakub Czarnecki
Financial Controller at Delin Ventures

Frequently asked questions

Who is Miguel Forte?
Miguel Forte is Chief Executive Officer of Kiji Therapeutics and serves as an ARM Board Member. He holds an MD and PhD and brings over 30 years of experience across clinical, academic, regulatory, and pharmaceutical industry settings, with expertise in research and development, manufacturing, regulatory affairs, medical affairs, and general management. He previously served as President of the International Society for Cell & Gene Therapy.
Where does Miguel Forte work?
Miguel Forte is Advisor at Delin Ventures and CEO at Kiji-tx website.
Where did Miguel Forte go to school?
Miguel Forte studied at University of Lisbon (MD, Medicine); University of Birmingham (PhD, Medicine; Immunology; Infectious Diseases); London School of Hygiene and Tropical Medicine, U. of London (DTM&H, Tropical Medicine).

Founder mafias

Same school

Shared employers

Also worked at Faculdade de Farmácia da Universidade de Lisboa1

JOana Ogando CampelloFounder at Sea4us